BIMEKIZUMAB IN BDMARD-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: IMPROVEMENTS IN PSARC OVER 24 WEEKS IN THE PHASE 3 BE OPTIMAL TRIAL

被引：0
|
作者：
McInnes, Iain [1 ]
Ink, Barbara [2 ]
Bajracharya, Rajan [2 ]
Taieb, Vanessa [3 ]
Tillett, William R. [4 ]
机构：
[1] Univ Glasgow, IBM Coll Med Vet & Life Sci, Glasgow, Scotland
[2] UCB Pharma, Rheumatol, Slough, England
[3] UCB Pharma, Rheumatol, Colombes, France
[4] Univ Bath, Royal Natl Hosp Rheumat Dis, Dept Life Sci, Bath, England
来源：
RHEUMATOLOGY | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P171
引用
收藏
页数：2
相关论文
共 50 条
  • [31] IMPROVEMENTS IN WORK PRODUCTIVITY WITH UP TO 104 WEEKS OF APREMILAST MONOTHERAPY: RESULTS FROM A PHASE 3B, RANDOMISED, CONTROLLED STUDY IN BIOLOGIC-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS
    Mease, P. J.
    Gladman, D. D.
    Davenport, E. K.
    Zhou, X.
    Guerette, B.
    Teng, L.
    Kaura, S.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1598 - 1598
  • [32] IMPROVEMENTS IN WORK PRODUCTIVITY WITH UP TO 104 WEEKS OF APREMILAST MONOTHERAPY: RESULTS FROM A PHASE 3B, RANDOMIZED, CONTROLLED STUDY IN BIOLOGIC-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS
    Mease, Philip J.
    Gladman, Dafna D.
    Davenport, Eric K.
    Zhou, Xiaolei
    Guerette, Benoit
    Teng, Lichen
    Kaura, Satyin
    Nash, Peter
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 14 - 14
  • [33] EARLY ONSET OF EFFICACY WITH APREMILAST MONOTHERAPY IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: A PHASE 3B, RANDOMIZED, CONTROLLED TRIAL
    Nash, P.
    Ohson, K.
    Walsh, J.
    Delev, N.
    Nguyen, D.
    Teng, L.
    Gomez-Reino, J. J.
    Aelion, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 143 - 143
  • [34] Bimekizumab Maintained Efficacy Responses in Patients with Active Psoriatic Arthritis: Up to 2-Year Results from Two Phase 3 Studies
    Walsh, Jessica A.
    Merola, Joseph F.
    Ritchlin, Christopher T.
    Tanaka, Yoshiya
    Favalli, Ennio Giulio
    McGonagle, Dennis
    Thaci, Diamant
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Tillett, William
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1206 - 1209
  • [35] Early and Sustained Modified Psarc Response in Psoriatic Arthritis Patients Treated with Ustekinumab: Results from 2 Phase 3 Studies
    McInnes, Iain B.
    Ritchlin, Christopher T.
    Rahman, Proton
    Puig Sanz, Lluis
    Gottlieb, Alice B.
    Li, Shu
    Song, Michael
    Randazzo, Bruce
    Wang, Yuhua
    Mendelsohn, Alan M.
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S685 - S686
  • [36] IXEKIZUMAB PROVIDES SUSTAINED IMPROVEMENT UP TO 52 WEEKS OF DISEASE ACTIVITY AS ASSESSED BY COMPOSITE MEASURE SCORES IN BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG (BDMARD)-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Coates, L. C.
    Husni, M. E.
    Shuler, C. L.
    Carlier, H.
    Lin, C-Y
    Mou, J.
    Lee, C. H.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 349 - 350
  • [37] Bimekizumab Maintained Efficacy Responses Through 52 Weeks in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients with Psoriatic Arthritis Who Were Responders at Week 16: Results from a Phase 3, Active-Reference Study
    Tillett, William R.
    Merola, Joseph
    Tanaka, Yoshiya
    Favalli, Ennio G.
    McGonagle, Dennis
    Walsh, Jessica A.
    Thaci, Diamant
    Ink, Barbara
    Bajracharya, Rajan
    Taieb, Vanessa
    Ritchlin, Christopher T.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2832 - 2834
  • [38] SUSTAINED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION WITH CERTOLIZUMAB PEGOL OVER 96 WEEKS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Kavanaugh, A.
    Gladman, D.
    van der Heijde, D.
    Purcaru, O.
    Mease, P. J.
    VALUE IN HEALTH, 2014, 17 (07) : A387 - A388
  • [39] Sustained Improvements in Workplace and Household Productivity and Social Participation with Certolizumab Pegol over 96 Weeks in Patients with Psoriatic Arthritis
    Kavanaugh, Arthur
    Gladman, Dafna D.
    van der Heijde, Desiree
    Purcaru, Oana
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S684 - S685
  • [40] Early and sustained efficacy with apremilast monotherapy in biological-naive patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)
    Nash, Peter
    Ohson, Kamal
    Walsh, Jessica
    Delev, Nikolay
    Nguyen, Dianne
    Teng, Lichen
    Gomez-Reino, Juan J.
    Aelion, Jacob A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (05) : 690 - 698
12345